FR2312261A1 - Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire - Google Patents

Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire

Info

Publication number
FR2312261A1
FR2312261A1 FR7516882A FR7516882A FR2312261A1 FR 2312261 A1 FR2312261 A1 FR 2312261A1 FR 7516882 A FR7516882 A FR 7516882A FR 7516882 A FR7516882 A FR 7516882A FR 2312261 A1 FR2312261 A1 FR 2312261A1
Authority
FR
France
Prior art keywords
mucosa
esp
immune response
contact
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7516882A
Other languages
English (en)
French (fr)
Other versions
FR2312261B1 (enExample
Inventor
Leon Georges De Chevance
Claude Hannoun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR7516882A priority Critical patent/FR2312261A1/fr
Publication of FR2312261A1 publication Critical patent/FR2312261A1/fr
Application granted granted Critical
Publication of FR2312261B1 publication Critical patent/FR2312261B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7516882A 1975-05-29 1975-05-29 Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire Granted FR2312261A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7516882A FR2312261A1 (fr) 1975-05-29 1975-05-29 Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7516882A FR2312261A1 (fr) 1975-05-29 1975-05-29 Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire

Publications (2)

Publication Number Publication Date
FR2312261A1 true FR2312261A1 (fr) 1976-12-24
FR2312261B1 FR2312261B1 (enExample) 1978-10-06

Family

ID=9155860

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7516882A Granted FR2312261A1 (fr) 1975-05-29 1975-05-29 Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire

Country Status (1)

Country Link
FR (1) FR2312261A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022426A3 (en) * 1979-07-04 1981-11-11 Ciba-Geigy Ag Nasal preparations, process for making same and their use
EP0045718A3 (de) * 1980-07-25 1983-01-19 Ciba-Geigy Ag Nasalpräparate und Verfahren zu deren Herstellung
US4512972A (en) * 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
EP0544612A3 (en) * 1991-11-25 1994-08-10 Nisshin Oil Mills Ltd Composition comprising an immunogen and a triglyceride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022426A3 (en) * 1979-07-04 1981-11-11 Ciba-Geigy Ag Nasal preparations, process for making same and their use
US4512972A (en) * 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
EP0045718A3 (de) * 1980-07-25 1983-01-19 Ciba-Geigy Ag Nasalpräparate und Verfahren zu deren Herstellung
EP0544612A3 (en) * 1991-11-25 1994-08-10 Nisshin Oil Mills Ltd Composition comprising an immunogen and a triglyceride

Also Published As

Publication number Publication date
FR2312261B1 (enExample) 1978-10-06

Similar Documents

Publication Publication Date Title
US6391318B1 (en) Vaccine compositions including chitosan for intranasal administration and use thereof
Tamura et al. Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine
CN1097467C (zh) 疫苗组合物
Brühl et al. Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine
KR890701127A (ko) 비루스 글리코 단백질 서브유니트 백신을 사용한 비루스 감염에 대한 비강내 면역화방법
JPH08508247A (ja) 粘膜表面への免疫原の輸送における重合的粘膜付着体
WO2007134385A1 (en) Immunogenic compositions
FR2312261A1 (fr) Procede et presentation pharmaceutique pour produire et favoriser une reponse immunitaire
Tateishi et al. CpG ODN G9. 1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
ES379642A1 (es) Procedimiento para la obtencion de vacunas perfeccionadas.
Xu et al. Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice
ES355121A1 (es) Procedimiento para la preparacion de una vacuna libre de antigenos.
CN105327345A (zh) 一种疫苗佐剂以及包含该佐剂的疫苗
Laver et al. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine
JP4889175B2 (ja) 感染性因子に対する免疫応答を刺激するための組成物および方法
PT721782E (pt) Vacina contra a gripe contendo toxina da tosse convulsa
Ashe et al. Inapparent herpes simplex virus infection in inoculated rabbits
MEIKLEJOHN et al. Influenza vaccination
SU439956A1 (ru) Способ получени штаммов вирусов дл стимул ции интерфероногенеза
CN104056266A (zh) 新喋呤佐剂及含新喋呤佐剂的疫苗
Knight Immunogenic properties of PR8 influenza virus after treatment with acid protease
Rouse et al. The Response of Ponies to Myxovirus influenzae A-equi 2 I. Serum and Antibody Titres Following Exposure
GB953992A (en) Vaccine products and method of preparing same
Idami Vaccination Methods in Adults

Legal Events

Date Code Title Description
ST Notification of lapse